Jewish General Hospital — Montreal, Quebec

Public research footprint of Jewish General Hospital, compiled from the ClinicalTrials.gov public registry.

905

Registered studies

286

Active

140

Recruiting now

440

Completed

117

Stopped or withdrawn

Most-studied conditions

Follicular Lymphoma · Acute Myeloid Leukemia Arising From Previous… · NSCLC (Non-small Cell Lung Cancer) · Diffuse Large B-cell Lymphoma

Recently updated registry entries

NCT06637332 — Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia (Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT01804686 — A Long-term Extension Study of PCI-32765 (Ibrutinib) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Jewish General Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.